search

The Real Deal Logo

Trending

Lawmakers reach sweeping housing deal with “good cause eviction,” new 421aLawmakers reach sweeping housing deal with “good cause eviction,” new 421a$1.8B in Parkmerced debt heads to special servicing$1.8B in Parkmerced debt heads to special servicingHarry Macklowe faces major losses on Miami, Midtown projectsHarry Macklowe faces major losses on Miami, Midtown projectsVornado, Rudin reveal plan for larger 350 Park Avenue projectVornado, Rudin reveal plan for larger 350 Park Avenue project
New York

Venture capital firm inks 14,000 sf lease at 230 Park Avenue

Apple Tree Sciences moving from Princeton, N.J. to open first New York office

230 Park Avenue
230 Park Avenue

UPDATED, 4:05 p.m., June 11: Venture capital firm Apple Tree Life Sciences has signed on for 14,169 square feet at 230 Park Avenue for the coming ten years.

Monday Properties and Invesco, which own the building, announced the deal today. Apple Tree Life Sciences, which invests in pharmaceuticals, biotech, medtech and health care services, is relocating from Princeton, N.J. to open its first office in New York City. Asking rent for the space was in the low $80s.

Apple Tree Life Sciences was represented by Ethan Silverstein of Cushman & Wakefield. Monday Properties was represented in-house by Jordan Berger, along with  JLL’s Paul Glickman, Frank Doyle, Jonathan Fanuzzi, David Kleiner and Matthew Polhemus.

Sign Up for the undefined Newsletter

The space will be built out by Monday Properties and designed by Gensler.

The lease follows an announcement in February that UrbanSpace will occupy 10,000 square feet at 230 Park Avenue. [NYO] – Claire Moses

Tags
Invesco Real EstateMonday Properties